ArticleInternational journal of endocrinology2020

Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria.

G Rendl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.